Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
Clinical trial NCT04766086 · COMPLETED
Trial details
- NCT number
- NCT04766086
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2023-04-27
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.